Shares of Medtronic PLC MDT shed 1.52% to $88.49 Tuesday, on what proved to be an all-around mixed trading session for the ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Here are two blue-chip value stocks I'm steadily accumulating right now. What makes this discount particularly compelling is ...

Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut ...

Budgeted spending for NIH BRAIN Initiative has plunged by more than half, from $680 million in 2023 to $320 million this year ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA).As the company's third R&D centre ...

Shares of Medtronic PLC MDT rallied 2.54% to $89.86 Monday, on what proved to be an all-around great trading session for the ...

The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report), with a price target of ...

Stifel Nicolaus analyst Rick Wise maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $87.00. The ...